25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CVM (Cel-sci) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cel-sci together

I guess you are interested in CEL-SCI Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Cel-sci’s Financial Insights
  • 📈 Technical Analysis (TA) – Cel-sci’s Price Targets

I'm going to help you getting a better view of CEL-SCI Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CEL-SCI Corp

I send you an email if I find something interesting about CEL-SCI Corp.

1. Quick Overview

1.1. Quick analysis of Cel-sci (30 sec.)










1.2. What can you expect buying and holding a share of Cel-sci? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.17
Expected worth in 1 year
$0.15
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-0.03
Return On Investment
-11.6%

For what price can you sell your share?

Current Price per Share
$0.22
Expected price per share
$0 - $0.3567
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cel-sci (5 min.)




Live pricePrice per Share (EOD)
$0.22
Intrinsic Value Per Share
$-2.07 - $-1.98
Total Value Per Share
$-1.89 - $-1.80

2.2. Growth of Cel-sci (5 min.)




Is Cel-sci growing?

Current yearPrevious yearGrowGrow %
How rich?$11.3m$15.2m-$3.4m-29.5%

How much money is Cel-sci making?

Current yearPrevious yearGrowGrow %
Making money-$6.8m-$7.8m$983.2k14.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cel-sci (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#607 / 910

Most Revenue
#848 / 910

Most Profit
#393 / 910

Most Efficient
#400 / 910
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cel-sci?

Welcome investor! Cel-sci's management wants to use your money to grow the business. In return you get a share of Cel-sci.

First you should know what it really means to hold a share of Cel-sci. And how you can make/lose money.

Speculation

The Price per Share of Cel-sci is $0.2161. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cel-sci.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cel-sci, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.17. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cel-sci.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.11-50.1%-0.11-49.2%-0.12-56.3%-0.13-60.0%-0.11-50.3%
Usd Book Value Change Per Share-0.03-13.2%-0.01-2.9%-0.05-25.3%0.001.5%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-13.2%-0.01-2.9%-0.05-25.3%0.001.5%0.00-0.1%
Usd Price Per Share0.40-1.13-2.18-6.00-4.23-
Price to Earnings Ratio-0.92--2.65--4.53--11.33--7.61-
Price-to-Total Gains Ratio-14.01-15.59--102.43-134.37-151.50-
Price to Book Ratio2.31-6.21-9.38-16.40-7,085.38-
Price-to-Total Gains Ratio-14.01-15.59--102.43-134.37-151.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2161
Number of shares4627
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (4627 shares)-29.0914.78
Gains per Year (4627 shares)-116.3559.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-116-12605949
20-233-2420118108
30-349-3580177167
40-465-4740237226
50-582-5900296285
60-698-7060355344
70-814-8220414403
80-931-9380473462
90-1047-10540532521
100-1164-11700591580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%3.037.00.07.5%7.0136.00.04.9%
Book Value Change Per Share2.02.00.050.0%2.010.00.016.7%8.012.00.040.0%20.020.00.050.0%50.082.011.035.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.0142.00.7%
Total Gains per Share2.02.00.050.0%2.010.00.016.7%8.012.00.040.0%20.020.00.050.0%50.082.011.035.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CEL-SCI Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.029-0.006-78%-0.055+91%0.003-993%0.000-99%
Book Value Per Share--0.1730.183-5%0.238-27%0.413-58%0.205-15%
Current Ratio--1.0691.174-9%1.583-32%4.460-76%2.940-64%
Debt To Asset Ratio--0.5600.564-1%0.535+5%0.453+24%0.751-25%
Debt To Equity Ratio--1.2721.328-4%1.165+9%0.931+37%814.438-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--16347769.41560025414.354-73%127184958.000-87%382098351.321-96%262238692.802-94%
Eps---0.108-0.106-2%-0.122+12%-0.130+20%-0.109+0%
Ev To Ebitda Ratio---0.692infnan%-4.913+610%infnan%infnan%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.064-0.071+10%-0.092+44%-0.084+31%-0.077+20%
Free Cash Flow To Equity Per Share---0.0020.006-134%-0.076+3903%-0.007+289%-0.004+96%
Gross Profit Margin--1.0001.034-3%1.0000%1.007-1%1.0030%
Intrinsic Value_10Y_max---1.978--------
Intrinsic Value_10Y_min---2.065--------
Intrinsic Value_1Y_max---0.292--------
Intrinsic Value_1Y_min---0.298--------
Intrinsic Value_3Y_max---0.807--------
Intrinsic Value_3Y_min---0.822--------
Intrinsic Value_5Y_max---1.234--------
Intrinsic Value_5Y_min---1.262--------
Market Cap13788714.310-89%26123809.41572411783.104-64%138780442.500-81%382713130.721-93%269787774.127-90%
Net Profit Margin----0%-0%-11220.1210%-37407.1480%
Operating Margin----0%-0%-15828.4630%-85191.9480%
Operating Ratio----0%-0%16204.168-100%62894.346-100%
Pb Ratio1.248-85%2.3106.205-63%9.375-75%16.403-86%7085.378-100%
Pe Ratio-0.499+46%-0.923-2.649+187%-4.528+390%-11.330+1127%-7.609+724%
Price Per Share0.216-85%0.4001.132-65%2.175-82%5.997-93%4.228-91%
Price To Free Cash Flow Ratio-0.846+46%-1.565-3.960+153%-6.036+286%-17.879+1042%-13.772+780%
Price To Total Gains Ratio-7.571+46%-14.01015.589-190%-102.427+631%134.374-110%151.504-109%
Quick Ratio--0.8420.492+71%0.758+11%4.105-79%2.587-67%
Return On Assets---0.275-0.257-7%-0.241-12%-0.204-26%-0.259-6%
Return On Equity---0.625-0.604-3%-0.524-16%-0.414-34%-410.169+65479%
Total Gains Per Share---0.029-0.006-78%-0.055+91%0.003-993%0.000-99%
Usd Book Value--11308632.00011738353.750-4%15200537.250-26%26358165.750-57%13063632.825-13%
Usd Book Value Change Per Share---0.029-0.006-78%-0.055+91%0.003-993%0.000-99%
Usd Book Value Per Share--0.1730.183-5%0.238-27%0.413-58%0.205-15%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--16347769.41560025414.354-73%127184958.000-87%382098351.321-96%262238692.802-94%
Usd Eps---0.108-0.106-2%-0.122+12%-0.130+20%-0.109+0%
Usd Free Cash Flow---4172927.000-4526107.250+8%-5863345.750+41%-5338038.350+28%-4911982.225+18%
Usd Free Cash Flow Per Share---0.064-0.071+10%-0.092+44%-0.084+31%-0.077+20%
Usd Free Cash Flow To Equity Per Share---0.0020.006-134%-0.076+3903%-0.007+289%-0.004+96%
Usd Market Cap13788714.310-89%26123809.41572411783.104-64%138780442.500-81%382713130.721-93%269787774.127-90%
Usd Price Per Share0.216-85%0.4001.132-65%2.175-82%5.997-93%4.228-91%
Usd Profit---7073062.000-6821000.750-4%-7804220.250+10%-8318505.500+18%-6961905.700-2%
Usd Revenue----0%-0%-47530.3860%-4439.5820%
Usd Total Gains Per Share---0.029-0.006-78%-0.055+91%0.003-993%0.000-99%
 EOD+3 -5MRQTTM+8 -24YOY+17 -155Y+11 -2210Y+13 -20

3.3 Fundamental Score

Let's check the fundamental score of CEL-SCI Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.499
Price to Book Ratio (EOD)Between0-11.248
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.842
Current Ratio (MRQ)Greater than11.069
Debt to Asset Ratio (MRQ)Less than10.560
Debt to Equity Ratio (MRQ)Less than11.272
Return on Equity (MRQ)Greater than0.15-0.625
Return on Assets (MRQ)Greater than0.05-0.275
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of CEL-SCI Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.927
Ma 20Greater thanMa 500.263
Ma 50Greater thanMa 1000.337
Ma 100Greater thanMa 2000.452
OpenGreater thanClose0.190
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About CEL-SCI Corp

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.

Fundamental data was last updated by Penke on 2025-03-30 01:22:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cel-sci earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cel-sci to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CEL-SCI Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1,122,012.1%+1,122,012.1%
5Y-1,122,012.1%10Y-3,740,714.8%+2,618,702.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--109.6%+109.6%
TTM--185.9%+185.9%
YOY--206.2%+206.2%
5Y-1,122,012.1%-408.8%-1,121,603.3%
10Y-3,740,714.8%-522.9%-3,740,191.9%
4.3.1.2. Return on Assets

Shows how efficient Cel-sci is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cel-sci to the Biotechnology industry mean.
  • -27.5% Return on Assets means that Cel-sci generated $-0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CEL-SCI Corp:

  • The MRQ is -27.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -25.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.5%TTM-25.7%-1.8%
TTM-25.7%YOY-24.1%-1.6%
TTM-25.7%5Y-20.4%-5.3%
5Y-20.4%10Y-25.9%+5.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.5%-14.2%-13.3%
TTM-25.7%-14.6%-11.1%
YOY-24.1%-14.4%-9.7%
5Y-20.4%-15.5%-4.9%
10Y-25.9%-18.0%-7.9%
4.3.1.3. Return on Equity

Shows how efficient Cel-sci is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cel-sci to the Biotechnology industry mean.
  • -62.5% Return on Equity means Cel-sci generated $-0.63 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CEL-SCI Corp:

  • The MRQ is -62.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -60.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-62.5%TTM-60.4%-2.1%
TTM-60.4%YOY-52.4%-8.0%
TTM-60.4%5Y-41.4%-19.0%
5Y-41.4%10Y-41,016.9%+40,975.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-62.5%-17.6%-44.9%
TTM-60.4%-18.2%-42.2%
YOY-52.4%-19.1%-33.3%
5Y-41.4%-24.3%-17.1%
10Y-41,016.9%-26.0%-40,990.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CEL-SCI Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cel-sci is operating .

  • Measures how much profit Cel-sci makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cel-sci to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CEL-SCI Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1,582,846.3%+1,582,846.3%
5Y-1,582,846.3%10Y-8,519,194.8%+6,936,348.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.7%+223.7%
TTM--281.1%+281.1%
YOY--226.6%+226.6%
5Y-1,582,846.3%-393.8%-1,582,452.5%
10Y-8,519,194.8%-503.6%-8,518,691.2%
4.3.2.2. Operating Ratio

Measures how efficient Cel-sci is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CEL-SCI Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y16,204.168-16,204.168
5Y16,204.16810Y62,894.346-46,690.178
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.324-2.324
TTM-3.192-3.192
YOY-3.069-3.069
5Y16,204.1685.133+16,199.035
10Y62,894.3467.010+62,887.336
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CEL-SCI Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cel-sci is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.07 means the company has $1.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CEL-SCI Corp:

  • The MRQ is 1.069. The company is just able to pay all its short-term debts.
  • The TTM is 1.174. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.069TTM1.174-0.105
TTM1.174YOY1.583-0.408
TTM1.1745Y4.460-3.285
5Y4.46010Y2.940+1.519
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0693.776-2.707
TTM1.1743.930-2.756
YOY1.5834.470-2.887
5Y4.4605.748-1.288
10Y2.9406.099-3.159
4.4.3.2. Quick Ratio

Measures if Cel-sci is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cel-sci to the Biotechnology industry mean.
  • A Quick Ratio of 0.84 means the company can pay off $0.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CEL-SCI Corp:

  • The MRQ is 0.842. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.492. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.842TTM0.492+0.350
TTM0.492YOY0.758-0.266
TTM0.4925Y4.105-3.613
5Y4.10510Y2.587+1.518
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8423.102-2.260
TTM0.4923.367-2.875
YOY0.7584.358-3.600
5Y4.1055.731-1.626
10Y2.5876.427-3.840
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CEL-SCI Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cel-sci assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cel-sci to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.56 means that Cel-sci assets are financed with 56.0% credit (debt) and the remaining percentage (100% - 56.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CEL-SCI Corp:

  • The MRQ is 0.560. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.564. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.560TTM0.564-0.004
TTM0.564YOY0.535+0.028
TTM0.5645Y0.453+0.110
5Y0.45310Y0.751-0.298
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5600.340+0.220
TTM0.5640.340+0.224
YOY0.5350.318+0.217
5Y0.4530.364+0.089
10Y0.7510.393+0.358
4.5.4.2. Debt to Equity Ratio

Measures if Cel-sci is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cel-sci to the Biotechnology industry mean.
  • A Debt to Equity ratio of 127.2% means that company has $1.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CEL-SCI Corp:

  • The MRQ is 1.272. The company is able to pay all its debts with equity. +1
  • The TTM is 1.328. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.272TTM1.328-0.055
TTM1.328YOY1.165+0.163
TTM1.3285Y0.931+0.397
5Y0.93110Y814.438-813.507
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2720.399+0.873
TTM1.3280.407+0.921
YOY1.1650.389+0.776
5Y0.9310.428+0.503
10Y814.4380.460+813.978
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cel-sci generates.

  • Above 15 is considered overpriced but always compare Cel-sci to the Biotechnology industry mean.
  • A PE ratio of -0.92 means the investor is paying $-0.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CEL-SCI Corp:

  • The EOD is -0.499. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.923. Based on the earnings, the company is expensive. -2
  • The TTM is -2.649. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.499MRQ-0.923+0.424
MRQ-0.923TTM-2.649+1.725
TTM-2.649YOY-4.528+1.879
TTM-2.6495Y-11.330+8.681
5Y-11.33010Y-7.609-3.722
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.499-1.736+1.237
MRQ-0.923-2.674+1.751
TTM-2.649-3.229+0.580
YOY-4.528-3.337-1.191
5Y-11.330-6.386-4.944
10Y-7.609-7.280-0.329
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CEL-SCI Corp:

  • The EOD is -0.846. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.565. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.960. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.846MRQ-1.565+0.719
MRQ-1.565TTM-3.960+2.395
TTM-3.960YOY-6.036+2.075
TTM-3.9605Y-17.879+13.919
5Y-17.87910Y-13.772-4.107
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.846-2.257+1.411
MRQ-1.565-3.660+2.095
TTM-3.960-4.254+0.294
YOY-6.036-4.479-1.557
5Y-17.879-8.682-9.197
10Y-13.772-9.845-3.927
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cel-sci is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.31 means the investor is paying $2.31 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CEL-SCI Corp:

  • The EOD is 1.248. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.310. Based on the equity, the company is underpriced. +1
  • The TTM is 6.205. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD1.248MRQ2.310-1.062
MRQ2.310TTM6.205-3.895
TTM6.205YOY9.375-3.170
TTM6.2055Y16.403-10.197
5Y16.40310Y7,085.378-7,068.975
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2481.641-0.393
MRQ2.3102.266+0.044
TTM6.2052.443+3.762
YOY9.3752.468+6.907
5Y16.4033.790+12.613
10Y7,085.3784.287+7,081.091
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of CEL-SCI Corp.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets25,699
Total Liabilities14,390
Total Stockholder Equity11,309
 As reported
Total Liabilities 14,390
Total Stockholder Equity+ 11,309
Total Assets = 25,699

Assets

Total Assets25,699
Total Current Assets5,858
Long-term Assets19,841
Total Current Assets
Cash And Cash Equivalents 4,614
Other Current Assets 1,244
Total Current Assets  (as reported)5,858
Total Current Assets  (calculated)5,858
+/-0
Long-term Assets
Property Plant Equipment 15,935
Intangible Assets 148
Long-term Assets Other 3,758
Long-term Assets  (as reported)19,841
Long-term Assets  (calculated)19,841
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,480
Long-term Liabilities8,911
Total Stockholder Equity11,309
Total Current Liabilities
Short-term Debt 2,301
Accounts payable 1,999
Other Current Liabilities 1,180
Total Current Liabilities  (as reported)5,480
Total Current Liabilities  (calculated)5,480
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt8,786
Long-term Liabilities Other 125
Long-term Liabilities  (as reported)8,911
Long-term Liabilities  (calculated)8,911
+/-0
Total Stockholder Equity
Common Stock731
Retained Earnings -521,085
Other Stockholders Equity 531,663
Total Stockholder Equity (as reported)11,309
Total Stockholder Equity (calculated)11,309
+/-0
Other
Capital Stock731
Cash and Short Term Investments 4,614
Common Stock Shares Outstanding 65,326
Liabilities and Stockholders Equity 25,699
Net Debt 6,472
Net Invested Capital 11,309
Net Working Capital 378
Property Plant and Equipment Gross 15,935
Short Long Term Debt Total 11,086



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-311986-12-311986-09-301986-06-301986-03-311985-12-31
> Total Assets 
0
0
0
300
0
0
0
700
0
0
0
600
800
0
800
500
700
800
900
500
900
1,000
900
1,600
1,100
14,500
14,200
13,800
13,400
12,800
12,300
11,600
10,900
9,700
8,600
8,100
6,800
6,000
6,200
6,400
5,100
5,100
6,400
11,900
11,000
9,000
7,700
6,300
17,400
17,200
15,800
14,400
14,400
10,800
8,900
7,600
8,100
17,395
15,207
13,809
11,264
7,333
5,270
4,509
4,920
3,958
3,356
3,771
3,771
2,900
3,009
2,915
3,514
3,053
6,568
5,514
5,514
3,350
2,601
3,092
2,976
3,092
2,728
9,653
9,653
7,083
20,644
20,731
20,731
17,650
15,216
14,684
14,684
14,253
18,543
46,028
46,028
45,027
42,108
37,805
34,164
30,771
23,742
18,625
16,678
18,384
19,926
16,067
22,012
18,491
14,750
10,839
24,798
21,819
25,159
19,230
19,553
12,726
21,496
15,448
19,985
15,519
14,481
11,598
9,928
8,726
8,437
22,924
22,174
23,090
21,701
29,586
25,933
24,755
28,485
27,623
29,508
34,717
42,035
40,536
49,614
48,365
79,642
75,870
69,672
64,161
56,890
50,524
44,558
38,195
32,319
30,528
28,710
30,048
24,068
26,992
25,699
25,69926,99224,06830,04828,71030,52832,31938,19544,55850,52456,89064,16169,67275,87079,64248,36549,61440,53642,03534,71729,50827,62328,48524,75525,93329,58621,70123,09022,17422,9248,4378,7269,92811,59814,48115,51919,98515,44821,49612,72619,55319,23025,15921,81924,79810,83914,75018,49122,01216,06719,92618,38416,67818,62523,74230,77134,16437,80542,10845,02746,02846,02818,54314,25314,68414,68415,21617,65020,73120,73120,6447,0839,6539,6532,7283,0922,9763,0922,6013,3505,5145,5146,5683,0533,5142,9153,0092,9003,7713,7713,3563,9584,9204,5095,2707,33311,26413,80915,20717,3958,1007,6008,90010,80014,40014,40015,80017,20017,4006,3007,7009,00011,00011,9006,4005,1005,1006,4006,2006,0006,8008,1008,6009,70010,90011,60012,30012,80013,40013,80014,20014,5001,1001,6009001,0009005009008007005008000800600000700000300000
   > Total Current Assets 
0
0
0
200
0
0
0
500
0
0
0
200
400
0
400
100
300
400
600
200
500
600
500
1,300
800
14,200
13,900
13,400
13,000
12,500
11,900
11,000
10,300
9,100
7,700
6,300
4,900
4,200
4,300
4,500
3,600
3,600
4,500
10,500
9,800
7,600
6,300
5,100
16,200
16,000
14,700
13,400
13,400
9,700
7,900
6,600
7,100
16,431
14,189
12,549
9,995
6,047
3,941
3,284
3,639
2,819
2,238
2,740
2,740
2,124
2,284
2,189
2,832
2,408
5,919
4,808
4,808
2,657
1,905
2,411
2,326
2,411
2,096
9,048
9,048
6,403
19,935
11,486
11,486
717
3,493
1,348
1,348
1,110
5,975
35,592
35,592
36,020
33,188
29,095
25,653
22,468
15,575
9,021
7,325
9,282
11,049
7,442
13,597
10,205
6,236
2,512
16,611
13,850
17,349
11,649
12,313
5,695
14,668
8,833
13,703
9,434
8,577
5,888
4,522
3,483
3,366
4,237
3,641
4,709
3,441
11,439
7,927
6,754
10,592
9,815
10,747
15,807
22,685
17,697
23,698
19,867
49,731
45,272
41,867
37,275
30,955
25,436
20,404
12,574
7,732
6,918
6,154
8,511
3,542
6,056
5,858
5,8586,0563,5428,5116,1546,9187,73212,57420,40425,43630,95537,27541,86745,27249,73119,86723,69817,69722,68515,80710,7479,81510,5926,7547,92711,4393,4414,7093,6414,2373,3663,4834,5225,8888,5779,43413,7038,83314,6685,69512,31311,64917,34913,85016,6112,5126,23610,20513,5977,44211,0499,2827,3259,02115,57522,46825,65329,09533,18836,02035,59235,5925,9751,1101,3481,3483,49371711,48611,48619,9356,4039,0489,0482,0962,4112,3262,4111,9052,6574,8084,8085,9192,4082,8322,1892,2842,1242,7402,7402,2382,8193,6393,2843,9416,0479,99512,54914,18916,4317,1006,6007,9009,70013,40013,40014,70016,00016,2005,1006,3007,6009,80010,5004,5003,6003,6004,5004,3004,2004,9006,3007,7009,10010,30011,00011,90012,50013,00013,40013,90014,2008001,3005006005002006004003001004000400200000500000200000
       Cash And Cash Equivalents 
0
0
0
100
0
0
0
400
0
0
0
0
300
0
300
0
300
400
500
0
400
500
300
100
500
14,000
13,700
3,200
1,100
1,600
2,400
2,200
2,100
2,200
2,600
3,400
2,700
2,700
3,700
3,900
3,000
3,000
3,900
3,500
5,000
3,700
3,400
3,500
9,800
3,000
2,500
2,800
2,800
2,700
2,500
2,700
4,600
11,978
9,484
6,909
3,713
2,146
2,592
1,784
2,476
2,206
1,765
2,079
2,079
1,483
1,707
1,753
2,449
1,925
5,365
4,264
4,264
2,173
1,489
1,958
1,886
1,958
1,361
8,080
8,080
5,870
19,453
10,993
10,993
265
3,161
711
711
654
5,571
33,568
33,568
34,012
30,476
26,568
20,854
17,741
10,576
4,261
3,462
5,268
7,222
3,941
10,736
6,986
3,484
42
13,494
10,606
14,286
8,514
9,461
2,614
11,230
5,727
10,422
6,052
5,219
2,918
2,387
1,530
1,232
2,369
2,143
3,062
2,347
10,310
6,682
5,514
9,485
8,445
9,383
14,330
20,137
15,509
21,860
6,431
35,958
36,060
37,110
34,283
28,074
22,672
18,017
10,046
5,135
4,146
3,241
5,309
385
4,738
4,614
4,6144,7383855,3093,2414,1465,13510,04618,01722,67228,07434,28337,11036,06035,9586,43121,86015,50920,13714,3309,3838,4459,4855,5146,68210,3102,3473,0622,1432,3691,2321,5302,3872,9185,2196,05210,4225,72711,2302,6149,4618,51414,28610,60613,494423,4846,98610,7363,9417,2225,2683,4624,26110,57617,74120,85426,56830,47634,01233,56833,5685,5716547117113,16126510,99310,99319,4535,8708,0808,0801,3611,9581,8861,9581,4892,1734,2644,2645,3651,9252,4491,7531,7071,4832,0792,0791,7652,2062,4761,7842,5922,1463,7136,9099,48411,9784,6002,7002,5002,7002,8002,8002,5003,0009,8003,5003,4003,7005,0003,5003,9003,0003,0003,9003,7002,7002,7003,4002,6002,2002,1002,2002,4001,6001,1003,20013,70014,0005001003005004000500400300030003000000400000100000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,800
3,200
2,000
3,745
3,734
3,761
3,790
3,136
576
593
593
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
0
0
0
1,585
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,151
11,152
6,151
1,911
0
0
0
0
0
0
0
0
16
51
0
0
005116000000001,9116,15111,15211,15100000000000000000000000000000000000000000010101,585000200200000000000000000000000000005935935763,1363,7903,7613,7343,7452,0003,2004,800000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,100
100
100
100
200
700
700
300
500
400
900
400
100
100
400
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
88
60
39
51
54
76
40
26
48
58
31
31
24
36
47
16
50
53
21
21
46
16
21
15
21
30
36
36
55
90
57
57
73
35
0
27
0
0
0
40
0
0
0
458
169
414
457
9
101
26
159
15
40
164
74
46
135
80
82
156
37
158
87
378
655
791
395
4
4
272
218
48
137
120
119
129
123
118
63
91
62
255
55
55
55
55
55
55
0
0
-2,002
-1,849
-1,894
-2,110
0
-2,347
0
0
0
0
0000-2,3470-2,110-1,894-1,849-2,002005555555555552556291631181231291191201374821827244395791655378871583715682801354674164401515926101945741416945800040000270357357579055363630211521164621215350164736243131584826407654513960881001001001001001001001001001001001001001001001001001001004001001004009004005003007007002001001001001,10000000000000000000000000
       Other Current Assets 
0
0
0
100
0
0
0
100
0
0
0
200
100
0
100
100
0
0
100
200
100
100
200
100
200
100
100
10,000
11,200
10,200
9,200
8,300
7,800
6,000
4,700
2,800
2,100
1,100
300
500
500
500
500
6,900
4,700
3,800
2,800
1,500
6,300
12,900
12,100
10,500
10,500
6,900
500
600
400
621
911
1,839
2,442
711
697
866
474
176
70
629
177
232
185
31
15
15
15
523
15
15
15
433
425
433
5
541
15
15
15
50
15
15
15
42
15
8
1
1,625
1,585
985
951
1,050
2,956
3,083
3,006
2,732
2,484
2,543
2,428
1,958
1,709
1,893
1,452
1,379
1,724
1,688
1,569
1,602
1,461
1,476
1,864
1,617
1,560
1,432
1,308
1,566
1,437
1,271
1,204
976
806
880
346
365
434
356
234
525
367
565
1,506
2,188
630
770
987
9,156
724
987
709
2,764
2,387
2,528
2,597
520
550
697
602
0
1,244
1,24406026975505202,5972,5282,3872,7647099877249,1569877706302,1881,5065653675252343564343653468808069761,2041,2711,4371,5661,3081,4321,5601,6171,8641,4761,4611,6021,5691,6881,7241,3791,4521,8931,7091,9582,4282,5432,4842,7323,0063,0832,9561,0509519851,5851,62518154215151550151515541543342543315151552315151531185232177629701764748666977112,4421,8399116214006005006,90010,50010,50012,10012,9006,3001,5002,8003,8004,7006,9005005005005003001,1002,1002,8004,7006,0007,8008,3009,20010,20011,20010,000100100200100200100100200100001001000100200000100000100000
   > Long-term Assets 
0
0
0
100
0
0
0
200
0
0
0
400
400
0
400
400
400
400
300
300
400
400
400
300
300
300
300
400
400
300
400
600
600
600
900
1,800
1,900
1,800
1,900
1,900
1,500
1,500
1,900
1,400
1,200
1,400
1,400
1,200
1,200
1,200
1,100
1,000
1,000
1,100
1,000
1,000
1,000
964
1,018
1,260
1,269
1,287
1,328
1,225
1,281
1,139
1,118
1,031
1,031
776
725
726
683
646
650
705
705
693
696
681
650
681
632
605
605
680
709
0
9,245
16,933
11,723
13,335
13,335
13,143
12,568
10,436
10,436
9,007
8,919
8,710
8,510
8,303
8,167
9,605
9,354
9,102
8,877
8,626
8,415
8,285
8,514
8,327
8,187
7,969
7,810
7,581
7,240
7,031
6,828
6,614
6,282
6,085
5,904
5,711
5,406
5,243
5,071
18,687
18,533
18,381
18,260
18,148
18,006
18,001
17,892
17,808
18,760
18,910
19,350
22,839
25,916
28,498
29,910
30,598
27,804
26,886
25,934
25,088
24,153
25,621
24,587
23,610
22,556
21,537
20,526
20,936
19,841
19,84120,93620,52621,53722,55623,61024,58725,62124,15325,08825,93426,88627,80430,59829,91028,49825,91622,83919,35018,91018,76017,80817,89218,00118,00618,14818,26018,38118,53318,6875,0715,2435,4065,7115,9046,0856,2826,6146,8287,0317,2407,5817,8107,9698,1878,3278,5148,2858,4158,6268,8779,1029,3549,6058,1678,3038,5108,7108,9199,00710,43610,43612,56813,14313,33513,33511,72316,9339,24507096806056056326816506816966937057056506466837267257761,0311,0311,1181,1391,2811,2251,3281,2871,2691,2601,0189641,0001,0001,0001,1001,0001,0001,1001,2001,2001,2001,4001,4001,2001,4001,9001,5001,5001,9001,9001,8001,9001,8009006006006004003004004003003003003004004004003003004004004004000400400000200000100000
       Property Plant Equipment 
0
0
0
100
0
0
0
100
0
0
0
100
100
0
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
100
300
300
400
300
1,200
1,200
1,200
1,100
1,100
1,000
1,000
1,100
900
800
900
900
800
700
700
600
600
600
600
500
500
400
441
470
595
601
629
634
621
593
554
513
474
474
334
304
279
247
220
212
234
234
226
204
182
158
182
112
92
92
108
133
234
234
685
1,855
1,325
1,325
1,340
1,240
1,201
1,201
1,206
1,297
1,265
1,175
1,131
1,098
1,033
936
834
730
631
572
579
538
489
463
424
437
403
396
364
340
307
296
267
251
226
230
219
201
16,793
16,647
16,504
16,362
16,219
16,082
16,087
15,949
15,826
16,779
16,927
17,368
20,855
23,945
26,535
27,720
28,412
27,557
26,651
25,712
24,711
23,847
23,008
22,005
21,018
19,974
18,964
17,962
16,976
15,935
15,93516,97617,96218,96419,97421,01822,00523,00823,84724,71125,71226,65127,55728,41227,72026,53523,94520,85517,36816,92716,77915,82615,94916,08716,08216,21916,36216,50416,64716,7932012192302262512672963073403643964034374244634895385795726317308349361,0331,0981,1311,1751,2651,2971,2061,2011,2011,2401,3401,3251,3251,85568523423413310892921121821581822042262342342122202472793043344744745135545936216346296015954704414005005006006006006007007008009009008009001,1001,0001,0001,1001,1001,2001,2001,200300400300300100-200-200-200-200-200-200-200-200-200-200-200-200-200-200-200-2000100100000100000100000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
300
300
0
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
200
200
0
400
200
400
400
500
500
500
500
500
500
400
400
500
500
400
500
508
533
526
528
518
509
465
456
445
465
418
418
427
421
448
435
425
438
472
472
467
491
485
477
485
505
513
513
572
576
541
541
563
570
587
587
540
415
423
423
386
374
356
404
390
434
414
400
387
402
384
359
344
335
318
317
322
334
324
314
308
301
292
282
273
266
257
247
239
232
223
215
207
227
258
253
243
272
312
311
312
311
313
300
292
279
276
248
235
222
212
202
192
183
198
188
180
173
165
148
1481651731801881981831922022122222352482762792923003133113123113122722432532582272072152232322392472572662732822923013083143243343223173183353443593844023874004144343904043563743864234234155405875875705635415415765725135135054854774854914674724724384254354484214274184184654454564655095185285265335085004005005004004005005005005005005004004002004000200200300300300300300300300300300300300300300300300300300300300300300300300300030030000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
523
548
665
668
657
695
604
688
585
605
558
449
442
421
448
435
425
437
472
472
467
491
499
492
533
520
513
519
572
576
9,011
9,025
16,248
9,868
12,011
11,487
11,359
11,328
9,235
9,017
7,801
7,623
7,445
7,335
7,172
7,069
8,571
8,417
8,268
8,147
7,994
7,843
7,707
0
7,837
0
7,545
7,373
0
6,844
6,667
6,488
0
0
5,818
5,653
0
1,918
0
1,903
1,894
1,886
0
1,671
0
0
0
0
0
1,671
1,671
1,671
16,995
0
0
1,911
1,911
0
0
0
0
105
2,421
2,400
0
0
0
0
0
0
0000002,4002,42110500001,9111,9110016,9951,6711,6711,671000001,67101,8861,8941,90301,91805,6535,818006,4886,6676,84407,3737,54507,83707,7077,8437,9948,1478,2688,4178,5717,0697,1727,3357,4457,6237,8019,0179,23511,32811,35911,48712,0119,86816,2489,0259,011576572519513520533492499491467472472437425435448421442449558605585688604695657668665548523000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
400
0
0
0
300
0
0
0
700
500
0
500
500
400
600
500
500
500
600
500
700
300
200
100
500
500
400
500
700
500
400
600
1,400
1,300
1,400
1,400
1,600
900
900
1,600
300
600
400
400
500
400
100
300
400
400
400
200
500
300
595
517
847
790
410
427
508
2,218
2,040
2,004
2,709
2,709
2,126
1,784
1,690
359
484
305
216
216
237
262
987
238
987
255
10,584
10,584
10,692
7,623
6,061
6,061
6,490
5,509
3,848
3,848
4,374
7,641
37,187
37,187
10,364
7,426
9,950
11,286
20,120
14,558
9,547
8,566
12,142
10,912
9,040
10,390
6,945
6,951
4,138
9,685
14,463
10,121
8,787
7,714
12,383
17,569
20,678
16,453
18,457
18,254
12,554
5,495
11,802
13,747
26,261
27,008
26,149
22,952
29,586
23,225
23,800
27,338
22,489
22,540
22,509
23,020
20,810
20,778
19,033
19,848
19,336
18,320
19,033
18,161
18,360
17,966
18,048
17,530
17,313
16,060
15,743
15,595
14,125
14,390
14,39014,12515,59515,74316,06017,31317,53018,04817,96618,36018,16119,03318,32019,33619,84819,03320,77820,81023,02022,50922,54022,48927,33823,80023,22529,58622,95226,14927,00826,26113,74711,8025,49512,55418,25418,45716,45320,67817,56912,3837,7148,78710,12114,4639,6854,1386,9516,94510,3909,04010,91212,1428,5669,54714,55820,12011,2869,9507,42610,36437,18737,1877,6414,3743,8483,8485,5096,4906,0616,0617,62310,69210,58410,5842559872389872622372162163054843591,6901,7842,1262,7092,7092,0042,0402,2185084274107908475175953005002004004004003001004005004004006003001,6009009001,6001,4001,4001,3001,4006004005007005004005005001002003007005006005005005006004005005000500700000300000400000
   > Total Current Liabilities 
0
0
0
400
0
0
0
200
0
0
0
400
500
0
500
500
400
600
400
500
400
500
400
600
300
100
100
400
300
300
400
500
300
200
300
500
200
300
300
500
300
300
500
300
600
100
300
500
400
100
300
400
400
300
200
400
300
567
488
823
765
385
402
477
1,189
894
1,925
2,049
2,049
1,832
1,669
1,657
359
484
305
216
216
237
259
173
235
173
252
1,938
1,938
2,240
1,313
1,228
1,228
1,909
1,337
3,841
3,841
4,361
6,567
37,173
37,173
2,130
2,236
3,295
2,747
15,200
11,021
7,225
4,947
2,026
2,027
1,913
1,783
1,879
2,968
3,545
3,379
3,321
3,326
3,153
3,791
3,679
5,273
6,851
5,682
5,090
5,282
4,012
3,794
8,408
10,240
10,845
10,596
10,857
8,377
9,227
5,892
5,471
4,228
3,020
4,566
5,271
4,651
4,266
7,334
5,823
5,157
3,937
3,333
4,474
4,015
4,664
4,742
5,312
5,292
5,586
4,867
5,087
5,506
4,616
5,480
5,4804,6165,5065,0874,8675,5865,2925,3124,7424,6644,0154,4743,3333,9375,1575,8237,3344,2664,6515,2714,5663,0204,2285,4715,8929,2278,37710,85710,59610,84510,2408,4083,7944,0125,2825,0905,6826,8515,2733,6793,7913,1533,3263,3213,3793,5452,9681,8791,7831,9132,0272,0264,9477,22511,02115,2002,7473,2952,2362,13037,17337,1736,5674,3613,8413,8411,3371,9091,2281,2281,3132,2401,9381,9382521732351732592372162163054843591,6571,6691,8322,0492,0491,9258941,1894774023857658234885673004002003004004003001004005003001006003005003003005003003002005003002003005004003003004001001003006004005004005004006004005005000500400000200000400000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
100
200
0
200
0
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
200
200
200
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,047
1,135
1,135
783
837
840
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
656
0
200
200
570
0
1,107
1,107
1,104
1,104
1,104
1,104
1,104
4,929
4,999
2,955
127
0
127
1,111
1,112
1,112
1,112
1,116
1,112
1,112
1,113
1,113
1,113
1,279
1,258
1,111
5
2
257
671
992
326
994
875
1,177
5
843
848
0
126,848,117
674
964
977
1,008
1,070
1,125
172
692
699
764
1,611
1,674
1,731
1,791
1,850
1,909
1,969
4,063
2,100
4,337
0
2,301
2,30104,3372,1004,0631,9691,9091,8501,7911,7311,6741,6117646996921721,1251,0701,008977964674126,848,117084884351,177875994326992671257251,1111,2581,2791,1131,1131,1131,1121,1121,1161,1121,1121,1121,11112701272,9554,9994,9291,1041,1041,1041,1041,1041,1071,10705702002000656000000011000000008408377831,1351,1351,047000000000000000000000002002002002001001001001000000000000000000010000200020010000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,122
0
0
0
13,887
0
0
0
13,011
249
208
13,486
14,206
14,130
14,472
13,337
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000013,33714,47214,13014,20613,48620824913,01100013,8870001,1220000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
300
0
300
400
400
400
400
500
400
500
400
400
300
100
0
100
100
100
200
200
300
200
300
300
100
100
100
200
100
100
200
300
100
100
300
500
400
100
300
400
400
300
200
400
300
567
488
823
765
385
402
476
1,114
774
766
736
736
750
518
482
265
139
189
143
143
119
153
74
133
74
112
98
98
230
182
248
248
258
291
428
428
1,245
1,532
793
793
731
759
1,497
938
942
1,274
739
632
708
703
593
410
466
1,176
1,924
1,628
1,346
1,364
1,161
1,642
1,704
3,158
5,129
3,856
3,770
4,437
3,092
2,741
7,075
8,352
8,196
7,873
7,687
6,253
5,744
4,903
4,159
2,079
1,586
1,439
1,140
944
2,023
3,093
2,391
2,144
1,676
1,193
1,317
853
1,618
1,600
1,889
1,743
2,010
1,144
1,016
1,369
1,448
1,999
1,9991,4481,3691,0161,1442,0101,7431,8891,6001,6188531,3171,1931,6762,1442,3913,0932,0239441,1401,4391,5862,0794,1594,9035,7446,2537,6877,8738,1968,3527,0752,7413,0924,4373,7703,8565,1293,1581,7041,6421,1611,3641,3461,6281,9241,1764664105937037086327391,2749429381,4977597317937931,5321,245428428291258248248182230989811274133741531191431431891392654825187507367367667741,11447640238576582348856730040020030040040030010040050030010010030020010010020010010010030030020030020020010010010001003004004005004005004004004004003000300000000000000
       Other Current Liabilities 
0
0
0
400
0
0
0
200
0
0
0
300
0
0
0
100
0
100
0
0
0
0
0
200
0
0
100
300
200
200
200
300
0
0
0
100
0
100
100
100
0
0
100
0
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75
121
113
178
30
180
203
236
94
344
117
73
73
118
106
99
100
99
140
1,840
1,840
2,009
1,131
980
980
880
1,047
3,214
3,055
2,536
5,035
35,272
35,124
170
248
424
1,809
839
4,693
1,362
1,236
1,318
1,324
1,320
135
175
88
382
510
736
160
753
909
736
403
337
590
1,189
317
538
256
216
1,437
1,529
1,722
1,868
2,124
2,513
14
1,312
1,266
1,433
1,167
2,162
1,924
214
2,041
2,283
919
437
2
1,546
1,489
1,314
1,351
1,573
1,641
1,607
-340
1,971
-200
0
1,180
1,1800-2001,971-3401,6071,6411,5731,3511,3141,4891,54624379192,2832,0412141,9242,1621,1671,4331,2661,312142,5132,1241,8681,7221,5291,4372162565383171,189590337403736909753160736510382881751351,3201,3241,3181,2361,3624,6938391,80942424817035,12435,2725,0352,5363,0553,2141,0478809809801,1312,0091,8401,840140991009910611873731173449423620318030178113121750000000000000000000500010000100100100010000030020020020030010000200000001000100000300000200000400000
   > Long-term Liabilities 
0
0
0
0
0
0
0
100
0
0
0
300
0
0
0
0
0
0
100
0
100
100
100
100
0
100
0
100
200
100
100
200
200
200
300
900
1,100
1,100
1,100
1,100
600
600
1,100
20
20
300
100
30
30
30
0
30
30
100
30
100
30
28
28
25
25
25
25
31
1,030
1,146
80
660
660
294
114
33
0
0
0
1,170
1,170
0
3
814
3
814
3
8,646
8,646
8,453
6,310
0
4,833
4,581
4,172
7
7
14
1,074
14
14
8,233
5,190
6,655
8,539
4,921
3,537
2,322
3,618
10,116
8,885
7,128
8,607
5,066
3,984
593
6,306
11,142
6,795
5,634
3,924
8,703
12,296
13,827
10,771
13,367
12,973
8,543
1,701
3,394
3,506
15,417
16,412
15,292
14,575
20,359
17,334
18,329
23,111
19,470
17,974
17,237
18,369
16,544
13,444
13,211
14,691
15,399
14,987
14,559
14,146
13,697
13,224
12,736
12,237
11,728
11,193
10,656
10,089
9,509
8,911
8,9119,50910,08910,65611,19311,72812,23712,73613,22413,69714,14614,55914,98715,39914,69113,21113,44416,54418,36917,23717,97419,47023,11118,32917,33420,35914,57515,29216,41215,4173,5063,3941,7018,54312,97313,36710,77113,82712,2968,7033,9245,6346,79511,1426,3065933,9845,0668,6077,1288,88510,1163,6182,3223,5374,9218,5396,6555,1908,23314141,07414774,1724,5814,83306,3108,4538,6468,64638143814301,1701,17000033114294660660801,1461,0303125252525282830100301003030030303010030020201,1006006001,1001,1001,1001,1009003002002002001001002001000100010010010010001000000003000001000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
25
23
21
24
13
11
9
7
5
2
0
0
0
0
13,011
0
0
0
0
0
0
0
0
13,414
13,444
13,476
13,508
12,454
12,232
11,995
11,753
11,496
12,055
13,603
13,252
12,880
12,494
12,125
11,721
11,296
10,855
10,407
0
0
0
0
0
0
00000010,40710,85511,29611,72112,12512,49412,88013,25213,60312,05511,49611,75311,99512,23212,45413,50813,47613,44413,4140000000013,0110000257911132421232527000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
28
25
25
25
25
31
30
28
25
21
17
12
9
0
0
0
0
0
0
0
3
814
3
3
3
8,646
8,056
8,452
6,310
4,833
3,741
4,581
4,172
7
13
13
14
14
15
8,234
5,190
6,655
8,539
4,921
3,537
2,321
3,619
10,116
8,885
7,128
8,580
5,041
3,960
572
6,282
11,129
6,784
5,625
3,916
8,699
12,294
13,827
10,771
13,368
12,973
8,542
1,701
3,394
3,506
2,204
3,157
1,996
1,238
6,979
3,920
4,885
9,635
5,961
4,685
4,192
5,219
3,677
875
125
125
125
125
125
125
125
125
0
125
0
0
0
0
0
0
00000012501251251251251251251251258753,6775,2194,1924,6855,9619,6354,8853,9206,9791,2381,9963,1572,2043,5063,3941,7018,54212,97313,36810,77113,82712,2948,6993,9165,6256,78411,1296,2825723,9605,0418,5807,1288,88510,1163,6192,3213,5374,9218,5396,6555,1908,234151414131374,1724,5813,7414,8336,3108,4528,0568,64633381430000000912172125283031252525252828000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,537
2,322
3,613
10,111
8,880
7,123
8,575
5,036
3,956
567
6,276
11,123
6,779
5,620
3,912
8,694
12,289
13,822
10,766
13,362
12,968
8,538
1,659
3,353
3,468
2,167
3,118
1,961
1,203
6,945
3,888
4,855
9,610
5,939
4,560
4,067
0
3,552
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000003,55204,0674,5605,9399,6104,8553,8886,9451,2031,9613,1182,1673,4683,3531,6598,53812,96813,36210,76613,82212,2898,6943,9125,6206,77911,1236,2765673,9565,0368,5757,1238,88010,1113,6132,3223,537000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-100
0
0
0
400
0
0
0
-100
300
0
300
-9,500
300
200
400
-10,500
400
400
400
900
800
14,300
14,100
13,300
12,900
12,400
11,800
10,900
10,400
9,300
8,000
6,700
5,500
4,600
4,800
4,800
4,200
4,200
4,800
11,600
10,400
8,600
7,300
5,800
17,000
17,100
15,500
14,000
14,000
10,400
8,700
7,100
7,800
16,800
14,690
12,961
10,474
6,924
4,843
4,001
2,702
1,918
1,352
1,062
1,062
774
1,225
1,225
3,156
2,570
6,263
5,298
5,298
3,113
2,339
2,105
2,738
2,105
2,473
-931
-931
-3,609
13,021
14,670
14,670
11,160
9,707
10,836
10,836
9,879
10,902
8,841
8,841
34,664
34,682
27,855
22,878
10,650
9,184
9,079
8,113
6,242
9,014
7,027
11,622
11,546
7,799
6,700
15,113
7,356
15,037
10,443
11,839
343
3,927
-5,230
3,532
-2,939
-3,774
-956
4,433
-3,076
92
-3,337
-4,834
-3,058
-1,252
1
2,708
956
1,146
5,134
6,968
12,209
19,015
19,727
28,836
29,332
59,794
56,534
51,351
45,128
38,728
32,163
26,592
20,148
14,789
13,215
12,650
14,305
8,473
12,867
11,309
11,30912,8678,47314,30512,65013,21514,78920,14826,59232,16338,72845,12851,35156,53459,79429,33228,83619,72719,01512,2096,9685,1341,1469562,7081-1,252-3,058-4,834-3,33792-3,0764,433-956-3,774-2,9393,532-5,2303,92734311,83910,44315,0377,35615,1136,7007,79911,54611,6227,0279,0146,2428,1139,0799,18410,65022,87827,85534,68234,6648,8418,84110,9029,87910,83610,8369,70711,16014,67014,67013,021-3,609-931-9312,4732,1052,7382,1052,3393,1135,2985,2986,2632,5703,1561,2251,2257741,0621,0621,3521,9182,7024,0014,8436,92410,47412,96114,69016,8007,8007,1008,70010,40014,00014,00015,50017,10017,0005,8007,3008,60010,40011,6004,8004,2004,2004,8004,8004,6005,5006,7008,0009,30010,40010,90011,80012,40012,90013,30014,10014,300800900400400400-10,500400200300-9,5003000300-100000400000-100000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,300
0
0
0
0
0
0
0
0
0
0
0
200
200
200
204
205
205
205
208
243
220
235
266
344
373
373
493
584
612
651
655
720
721
721
723
727
745
761
745
815
827
827
846
1,142
1,157
1,157
1,175
1,178
1,208
1,208
1,297
1,462
1,920
1,920
2,043
2,047
2,049
2,060
2,079
2,106
2,147
2,300
2,566
2,729
2,731
3,089
3,092
3,099
310
559
583
660
819
915
915
1,120
1,124
1,301
1,349
1,451
1,560
1,909
2,165
92
119
133
166
196
280
278
300
341
352
360
373
385
387
398
408
430
432
433
433
434
434
437
438
447
474
500
541
543
0
731
7310543541500474447438437434434433433432430408398387385373360352341300278280196166133119922,1651,9091,5601,4511,3491,3011,1241,1209159158196605835593103,0993,0923,0892,7312,7292,5662,3002,1472,1062,0792,0602,0492,0472,0431,9201,9201,4621,2971,2081,2081,1781,1751,1571,1571,14284682782781574576174572772372172172065565161258449337337334426623522024320820520520520420020020000000000000-3,300000000000000000000000000000000000000000000
   Retained Earnings Total Equity000000-479,461-471,093-462,751-454,897-446,435-436,803-426,979-418,196-409,992-401,053-389,772-381,8350-366,179-357,111-353,726-348,878-336,793-330,346-331,592-316,665-310,650-305,942-299,754-294,761-290,296-281,870-285,668-284,554-280,705-271,860-274,201-264,358-259,928-247,372-239,527-232,305-229,861-216,495-212,161-210,461-206,013-205,300-202,990-200,423-199,587-191,094-187,512-185,195000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-100
0
0
0
-100
0
0
0
-200
-200
0
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-200
-300
-300
-300
-400
-400
-500
-500
-600
-700
-700
-600
-900
-900
-1,000
-1,100
-1,100
-1,200
-1,300
-1,300
-1,400
-1,400
-1,500
-100
-100
-100
-77
-90
-62
-33
26
-35
-20
-15
-1
-1,986
-2,027
-2,027
-1,960
-231
-2,002
-2,033
-2,065
-2,098
-14
-14
-6
-3
-1,691
-1,715
-1,691
-1,761
-1,773
-1,773
-1,809
-1,830
-1,860
-1,860
-1,929
-1,904
-1,965
-1,965
-2,131
-2,232
-2,259
-2,259
-2,463
-2,527
-2,627
-2,743
-2,868
-2,964
-3,034
-2,448
-2,504
-2,609
-2,712
-2,820
-2,867
-2,919
-2,967
-3,010
-3,054
-3,103
-3,101
0
0
0
-3,235
-3,235
0
0
-3,198
-3,198
0
0
-7,816
-7,816
0
0
-8,383
-8,383
0
0
-354,000
-354,000
0
0
0
0
430,385
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000430,3850000-354,000-354,00000-8,383-8,38300-7,816-7,81600-3,198-3,19800-3,235-3,235000-3,101-3,103-3,054-3,010-2,967-2,919-2,867-2,820-2,712-2,609-2,504-2,448-3,034-2,964-2,868-2,743-2,627-2,527-2,463-2,259-2,259-2,232-2,131-1,965-1,965-1,904-1,929-1,860-1,860-1,830-1,809-1,773-1,773-1,761-1,691-1,715-1,691-3-6-14-14-2,098-2,065-2,033-2,002-231-1,960-2,027-2,027-1,986-1-15-20-3526-33-62-90-77-100-100-100-1,500-1,400-1,400-1,300-1,300-1,200-1,100-1,100-1,000-900-900-600-700-700-600-500-500-400-400-300-300-300-200-200-200-200-200-200-200-200-200-200-200-200-200-200-200-200-200-2000-200-200000-100000-100000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
192,273
194,444
196,906
203,263
206,708
207,286
213,832
214,467
215,161
218,550
231,050
236,634
246,682
249,151
258,296
259,356
267,164
267,848
274,090
276,417
279,329
283,152
286,488
287,378
289,585
296,298
300,976
307,426
315,218
331,312
332,775
337,449
349,684
358,508
365,706
379,944
396,959
401,175
418,210
429,977
469,356
474,299
477,898
481,497
484,730
486,626
488,905
490,803
493,803
0
0
0
0
0
0
000000493,803490,803488,905486,626484,730481,497477,898474,299469,356429,977418,210401,175396,959379,944365,706358,508349,684337,449332,775331,312315,218307,426300,976296,298289,585287,378286,488283,152279,329276,417274,090267,848267,164259,356258,296249,151246,682236,634231,050218,550215,161214,467213,832207,286206,708203,263196,906194,444192,273000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
5,700
0
0
0
7,900
0
0
0
8,600
9,200
0
9,500
200
10,200
10,300
10,700
200
11,200
11,500
11,700
12,700
13,000
26,800
26,800
26,800
26,800
26,800
26,800
26,800
27,200
27,200
27,200
27,200
27,200
27,400
28,400
29,400
30,600
30,600
29,400
42,900
42,900
44,700
45,200
45,600
58,500
59,900
59,900
60,500
60,500
60,700
59,100
59,600
62,000
73,863
73,931
73,925
73,952
73,974
73,964
75,641
77,204
78,352
81,804
82,899
82,899
85,139
85,531
89,169
92,198
92,845
97,399
95,344
95,344
95,421
95,612
102,050
103,688
102,050
106,040
106,954
106,954
108,129
130,039
0
131,941
133,960
134,468
136,289
136,289
139,254
146,809
175,277
175,277
188,952
189,631
190,233
191,611
193,520
192,194
197,478
199,354
205,768
209,316
209,998
216,652
217,334
218,080
221,518
234,060
239,688
249,785
252,252
258,296
259,356
267,164
271,082
274,090
276,417
279,329
286,350
284,655
285,300
289,585
304,114
300,976
307,426
315,218
339,696
332,775
337,449
349,684
712,508
365,706
379,944
396,959
401,175
418,210
-408
469,356
474,299
477,898
481,497
484,730
486,626
488,905
490,803
493,803
499,832
505,951
514,810
515,833
0
531,663
531,6630515,833514,810505,951499,832493,803490,803488,905486,626484,730481,497477,898474,299469,356-408418,210401,175396,959379,944365,706712,508349,684337,449332,775339,696315,218307,426300,976304,114289,585285,300284,655286,350279,329276,417274,090271,082267,164259,356258,296252,252249,785239,688234,060221,518218,080217,334216,652209,998209,316205,768199,354197,478192,194193,520191,611190,233189,631188,952175,277175,277146,809139,254136,289136,289134,468133,960131,9410130,039108,129106,954106,954106,040102,050103,688102,05095,61295,42195,34495,34497,39992,84592,19889,16985,53185,13982,89982,89981,80478,35277,20475,64173,96473,97473,95273,92573,93173,86362,00059,60059,10060,70060,50060,50059,90059,90058,50045,60045,20044,70042,90042,90029,40030,60030,60029,40028,40027,40027,20027,20027,20027,20027,20026,80026,80026,80026,80026,80026,80026,80013,00012,70011,70011,50011,20020010,70010,30010,2002009,50009,2008,6000007,9000005,700000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-09-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-3,969
Gross Profit-3,969-3,969
 
Operating Income (+$)
Gross Profit-3,969
Operating Expense-22,383
Operating Income-26,352-26,352
 
Operating Expense (+$)
Research Development18,161
Selling General Administrative8,191
Selling And Marketing Expenses0
Operating Expense22,38326,352
 
Net Interest Income (+$)
Interest Income0
Interest Expense-746
Other Finance Cost-0
Net Interest Income-746
 
Pretax Income (+$)
Operating Income-26,352
Net Interest Income-746
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-26,920-25,784
EBIT - interestExpense = -26,920
-26,920
-26,175
Interest Expense746
Earnings Before Interest and Taxes (EBIT)-26,175-26,175
Earnings Before Interest and Taxes (EBITDA)-22,206
 
After tax Income (+$)
Income Before Tax-26,920
Tax Provision-0
Net Income From Continuing Ops-26,920-26,920
Net Income-26,920
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses26,352
Total Other Income/Expenses Net-568746
 

Technical Analysis of Cel-sci
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cel-sci. The general trend of Cel-sci is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cel-sci's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cel-sci Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CEL-SCI Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.3133 < 0.3498 < 0.3567.

The bearish price targets are: .

Know someone who trades $CVM? Share this with them.👇

CEL-SCI Corp Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CEL-SCI Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CEL-SCI Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CEL-SCI Corp. The current macd is -0.03859329.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cel-sci price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cel-sci. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cel-sci price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
CEL-SCI Corp Daily Moving Average Convergence/Divergence (MACD) ChartCEL-SCI Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CEL-SCI Corp. The current adx is 23.74.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cel-sci shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
CEL-SCI Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CEL-SCI Corp. The current sar is 0.1814.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
CEL-SCI Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CEL-SCI Corp. The current rsi is 30.93. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
CEL-SCI Corp Daily Relative Strength Index (RSI) ChartCEL-SCI Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CEL-SCI Corp. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cel-sci price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
CEL-SCI Corp Daily Stochastic Oscillator ChartCEL-SCI Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CEL-SCI Corp. The current cci is -104.79384494.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CEL-SCI Corp Daily Commodity Channel Index (CCI) ChartCEL-SCI Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CEL-SCI Corp. The current cmo is -40.45132726.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CEL-SCI Corp Daily Chande Momentum Oscillator (CMO) ChartCEL-SCI Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CEL-SCI Corp. The current willr is -73.01710731.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cel-sci is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CEL-SCI Corp Daily Williams %R ChartCEL-SCI Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CEL-SCI Corp.

CEL-SCI Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CEL-SCI Corp. The current atr is 0.03167207.

CEL-SCI Corp Daily Average True Range (ATR) ChartCEL-SCI Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CEL-SCI Corp. The current obv is 31,942,348.

CEL-SCI Corp Daily On-Balance Volume (OBV) ChartCEL-SCI Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CEL-SCI Corp. The current mfi is 34.57.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CEL-SCI Corp Daily Money Flow Index (MFI) ChartCEL-SCI Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CEL-SCI Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

CEL-SCI Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CEL-SCI Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.927
Ma 20Greater thanMa 500.263
Ma 50Greater thanMa 1000.337
Ma 100Greater thanMa 2000.452
OpenGreater thanClose0.190
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cel-sci with someone you think should read this too:
  • Are you bullish or bearish on Cel-sci? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cel-sci? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CEL-SCI Corp

I send you an email if I find something interesting about CEL-SCI Corp.


Comments

How you think about this?

Leave a comment

Stay informed about CEL-SCI Corp.

Receive notifications about CEL-SCI Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.